Join the club for FREE to access the whole archive and other member benefits.

Academy for Health and Lifespan Research Q&A with Harvard's David Sinclair

Rejuvenation human trials (cell reprogramming) possible in next 2 years

08-Mar-2019

Key points from article :

Academy will improve collaboration and communication of ageing and longevity research.

Leading scientific journals now regularly feature breakthroughs in our understanding of the ageing process.

FDA is willing to consider a change that defines ageing as a disease.

Smoking increases the risk of cancer fivefold - ageing increases it 1,000-fold.

Able to give animals 20 percent longer youth, not just 20 percent longer life.

Yet-to-be published research on reprogramming cells in vivo cause tissues to rejuvenate.

Technology could be tested in the clinic in the next two years.

Mentioned in this article:

Click on resource name for more details.

David Sinclair

Harvard professor. Author of Lifespan.

Harvard University

Private Ivy League research university in Massachusetts

Massachusetts Institute of Technology (MIT)

Private land-grant research university

Topics mentioned on this page:
Ageing Research, Stem Cells